Abstract
Malignant struma ovarii is a very rare disease. Only few cases are reported in literature. Because of its rarity, there are various approaches to its treatment. We describe a case of malignant struma ovarii, in a 37 year-old female who presented for non cyclici, chronich pelvic pain and the presence of a right ovarian cyst with mean diameter of 7 cm. The patient was treated with laparoscopic right ovariectomy and with multiple biopsies of omental, left ovary and utero-sacral legament. The patient underwent subsequently total thyroidectomy and radioidine (131I) ablation. A Medline literature search was performed; we found 48 cases of malignant struma ovarii. The therapeutic management of the disease is very different in the described case; particularly after surgical removing of the ovarian mass, the treatment is still controversial. We think that the management of malignant struma ovarii could be the same than carcinoma of the thyroid, so after surgical removing of ovarian neoplasm, we recommend thyroidectomy, radioteraphy with 131I and levothyroxyne suppressive theraphy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Osmanagaoglu M, Bozkaya H, Reis A. Malignant Struma ovarii: a case report and review of literature. Indian J Med Sci 2004, 58: 206–10.
Devaney K, Snyder R, Norris Hj, Tavassoli FA. Proliferative and hystologically malignant struma ovarii: a clinicopathologic stydy of 54 cases. Int J Gynecol Pathol 1993, 12: 333–43.
Makani S, Kim W, Gaba AR. Struma ovarii with a focus of papillary thyroid cancer: a case report and a review of literature. Gynecol Oncol 2004, 94: 835–9.
Matsuda K, Maehama T, Kanazawa K. Malignant struma ovarii with thyrotoxicosis. Gynecol Oncol 2001, 82: 575–7.
Checrallah A, Medlej R, Saadé C, Khayat G, Halaby G. Malignant struma ovarii: an unusual presentation. Thyroid 2001, 11: 889–92.
DeSimone CP, Lele SM, Modesitt SC. Malignant struma ovarii: a case report and a analysis of cases reported in literature with focus on survival and 131I theraphy. Gynecol Oncol 2003, 89: 543–8.
Carcinoma differenziato della tiroide linee guida SIE-AIMN-AIFM per il trattamento ed il follow-up. Anno 2004.
Links TP, van Tol KM, Jager PL, et al. Life expectancy in differentiated thyroid cancer: a novel approach to survival analysis. Endocr Relat Cancer 2005, 12: 273–80.
Giovanella L, Ceriani L, Ghelfo A, Keller F. Thyroglobulin assay 4 weeks after thyroidectomy predicts outcome in low-risk papillary thyroid carcinoma. Clin Chem Lab Med 2005, 43: 843–7.
Lubin E, Mechlis-Frish S, Zatz S, et al. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma. J Nucl Med 1994, 35: 257–62.
Rose PG, Arafah B, Abdul-Karima F. Malignant struma ovarii: recurrence and response to treatment monitored by thyroglobulin levels. Gynecol Oncol 1998, 70: 425–7.
Steed H, Chapman W, Laframboise S. Endometriosis—associated ovarian cancer: a clinicopatologic rewiew. J Obstet Gynaeol Can 2004, 26: 709–15.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mattucci, M.L., Dellera, A., Guerriero, A. et al. Malignant struma ovarii: A case report and review of the literature. J Endocrinol Invest 30, 517–520 (2007). https://doi.org/10.1007/BF03346337
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03346337